
Managing diabetes will be a less expensive proposition for more Americans in 2024. Sanofi has officially joined Novo Nordisk and Eli Lilly in lowering the cost of insulin to $35 a month for many patients. The three drugmakers are also drastically lowering the list prices for their insulin products. The price-cutting moves were first announced last… read on > read on >